Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, USA
Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.
BMJ Support Palliat Care. 2022 Dec;12(e6):e813-e820. doi: 10.1136/bmjspcare-2018-001572. Epub 2019 Mar 1.
This observational study explores the association between palliative care (PC) involvement and high-cost imaging utilisation for patients with cancer patients during the last 3 months of life.
Adult patients with cancer who died between 1 January 2012 and 31 May 2015 were identified. Referral to PC, intensity of PC service use, and non-emergent oncological imaging utilisation were determined. Associations between PC utilisation and proportion of patients imaged and mean number of studies per patient (mean imaging intensity (MII)) were assessed for the last 3 months and the last month of life. Similar analyses were performed for randomly matched case-control pairs (n = 197). Finally, the association between intensity of PC involvement and imaging utilisation was assessed.
3784 patients were included, with 3523 (93%) never referred to PC and 261 (7%) seen by PC, largely before the last month of life (61%). Similar proportions of patients with and without PC referral were imaged during the last 3 months, while a greater proportion of patients with PC referral were imaged in the last month of life. PC involvement was not associated with significantly different MII during either time frame. In the matched-pairs analysis, a greater proportion of patients previously referred to PC received imaging in the period between the first PC encounter and death, and in the last month of life. MII remained similar between PC and non-PC groups. Finally, intensity of PC services was similar for imaged and non-imaged patients in the final 3 months and 1 month of life. During these time periods, increased PC intensity was not associated with decreased MII.
PC involvement in end-of-life oncological care was not associated with decreased use of non-emergent, high-cost imaging. The role of advanced imaging in the PC setting requires further investigation.
本观察性研究旨在探讨在癌症患者生命的最后 3 个月中,姑息治疗(PC)的参与与高成本影像学应用之间的关联。
确定了 2012 年 1 月 1 日至 2015 年 5 月 31 日期间死亡的成年癌症患者。确定了对 PC 的转介、PC 服务使用强度以及非紧急肿瘤影像学应用情况。评估了 PC 使用与最后 3 个月和最后 1 个月中成像患者的比例以及每位患者的平均研究数量(平均成像强度(MII))之间的关联。对随机匹配的病例对照对(n = 197)进行了类似的分析。最后,评估了 PC 参与强度与影像学应用之间的关联。
纳入了 3784 名患者,其中 3523 名(93%)从未接受过 PC 转介,261 名(7%)接受过 PC 转介,主要在生命的最后一个月之前(61%)。有和没有 PC 转介的患者在最后 3 个月内接受影像学检查的比例相似,而接受 PC 转介的患者在生命的最后一个月内接受影像学检查的比例更高。在这两个时间框架内,PC 参与与 MII 没有显著差异。在匹配对分析中,与未接受 PC 转介的患者相比,以前接受过 PC 转介的患者在第一次 PC 就诊与死亡之间以及在生命的最后一个月内接受影像学检查的比例更高。PC 组和非 PC 组之间的 MII 相似。最后,在生命的最后 3 个月和 1 个月内,PC 服务强度对于接受和未接受影像学检查的患者相似。在这些时间段内,增加 PC 强度与 MII 降低无关。
在临终期癌症护理中,PC 的参与与非紧急、高成本影像学的使用减少无关。高级影像学在 PC 环境中的作用需要进一步研究。